IMMUCELL CORP Contracts & Agreements

Fifth Amendment of Indenture of Lease for Premises Located in Portland, Maine between the Company and TVP, LLC dated as of September 20, 2024 (Filed With SEC on September 24, 2024)

Fourth Amendment of Indenture of Lease for Premises Located in Portland, Maine between the Company and TVP, LLC dated as of June 11, 2024 (Filed With SEC on June 14, 2024)

At The Market Offering Agreement, dated April 9, 2024, by and between ImmuCell Corporation and Craig-Hallum Capital Group LLC (Filed With SEC on April 9, 2024)

Consent and First Amendment to Economic Recovery Loan Program Loan Agreement, dated April 8, 2024, by and between the Company and the Finance Authority of Maine (Filed With SEC on April 9, 2024)

Fifth Amended and Restated Incentive Compensation Agreement between the Company and Elizabeth L. Williams dated as of March 27, 2024 (Filed With SEC on April 1, 2024)

Fourth Amended and Restated Incentive Compensation Agreement between the Company and Bobbi Jo Brockmann dated as of March 27, 2024 (Filed With SEC on April 1, 2024)

Amending Agreement between the Company and Norbrook Laboratories Limited dated as of March 4, 2024 (Filed With SEC on March 6, 2024)

Allonge to and Amendment of Line of Credit between the Company and Gorham Savings Bank, dated February 22, 2024 (Filed With SEC on February 27, 2024)

Third Amendment of Indenture of Lease for Premises Located in Portland, Maine between the Company and TVP, LLC dated as of November 14, 2023 (Filed With SEC on November 16, 2023)

Amendment to Rights Agreement by and between ImmuCell Corporation and Equiniti Trust Company, LLC dated August 9, 2023 (Filed With SEC on August 10, 2023)

Term Note for $2,000,000 executed by ImmuCell Corporation in favor of Gorham Savings Bank dated July 17, 2023 (Filed With SEC on July 21, 2023)

Loan Agreement, by and between ImmuCell Corporation and Gorham Savings Bank dated July 17, 2023 (Filed With SEC on July 21, 2023)

Economic Recovery/SSBCI Program Loan Promissory Note for $1,000,000 executed by ImmuCell Corporation in favor of the Finance Authority of Maine dated July 17, 2023 (Filed With SEC on July 21, 2023)

Economic Recovery Loan Program Loan Agreement, by and between ImmuCell Corporation and the Finance Authority of Maine dated July 17, 2023 (Filed With SEC on July 21, 2023)

Amendment to the 2017 Stock Option and Incentive Plan of the Company (Filed With SEC on March 29, 2023)

Fourth Amended and Restated Incentive Compensation Agreement between the Company and Elizabeth L. Williams dated as of March 28, 2023 (Filed With SEC on March 29, 2023)

Amended and Restated Incentive Compensation Agreement between the Company and Michael F. Brigham dated as of March 28, 2023 (Filed With SEC on March 29, 2023)

Third Amended and Restated Incentive Compensation Agreement between the Company and Bobbi Jo Brockmann dated as of March 28, 2023 (Filed With SEC on March 29, 2023)

Allonge to and Amendment of Line of Credit Loan for up to $1,000,000 between the Company and Gorham Savings Bank dated March 23, 2022 (Filed With SEC on March 29, 2023)

Amendment to Rights Agreement dated as of August 10, 2022 (Filed With SEC on August 11, 2022)

Second Amended and Restated Incentive Compensation Agreement between the Company and Elizabeth L. Williams dated as of March 28, 2022 (Filed With SEC on March 30, 2022)

Amended and Restated Separation and Deferred Compensation Agreement between the Company and Michael F. Brigham dated as of March 28, 2022 (Filed With SEC on March 30, 2022)

Incentive Compensation Agreement between the Company and Michael F. Brigham dated as of March 28, 2022 (Filed With SEC on March 30, 2022)

Second Amended and Restated Incentive Compensation Agreement between the Company and Bobbi Jo Brockmann dated as of March 28, 2022 (Filed With SEC on March 30, 2022)

Securities Purchase Agreement, dated April 14, 2021, by and among ImmuCell Corporation and certain purchasers (Filed With SEC on April 15, 2021)

Amended and Restated Incentive Compensation Agreement between the Company and Bobbi Jo Brockmann dated as of March 29, 2021 (Filed With SEC on March 30, 2021)

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 30, 2021)

Loan Agreement for $1,500,000 executed by ImmuCell Corporation in favor of Gorham Savings Bank dated December 15, 2020 (Filed With SEC on December 17, 2020)

Term Note for $1,500,000 executed by ImmuCell Corporation in favor of Gorham Savings Bank dated December 15, 2020 (Filed With SEC on December 17, 2020)

Amended and Restated Incentive Compensation Agreement between the Company and Bobbi Jo Brockmann dated as of March 25, 2020 (Filed With SEC on March 27, 2020)

Severance Agreement between the Company and Michael F. Brigham dated as of March 25, 2020 (Filed With SEC on March 27, 2020)

Form of Incentive Stock Option Agreement (Filed With SEC on March 27, 2020)

Underwriting Agreement between the Company and Craig-Hallum Capital Group LLC, dated March 27, 2019 (Filed With SEC on March 29, 2019)

Incentive Compensation Agreement dated March 21, 2019 between the Company and Elizabeth L. Williams (Filed With SEC on March 22, 2019)

Underwriting Agreement between the Company and Craig-Hallum Capital Group LLC, dated December 19, 2017 (Filed With SEC on December 21, 2017)

Amendment to Supply Agreement between the Company and Plas-Pak Industries, Inc. (now owned by Nordson Corporation) dated as of July 24, 2017 (Filed With SEC on August 14, 2017)

Sixth Amendment to Rights Agreement dated as of August 10, 2017 (Filed With SEC on August 14, 2017)

2017 Stock Option and Incentive Plan of the Company (Filed With SEC on August 14, 2017)

Securities Purchase Agreement, dated July 27, 2017, by and among ImmuCell Corporation and the Purchasers named therein (Filed With SEC on July 27, 2017)

IMMUCELL CORPORATION Amendedand Restated Promissory Note ($2,560,000) given bythe Company in favor of TD Bank N.A. dated March 1, 2017. (Filed With SEC on March 30, 2017)

IMMUCELLCORPORATION Amendedand Restated Promissory Note ($3,940,000)given by the Company in favor of TD Bank N.A. datedMarch 1, 2017. (Filed With SEC on March 30, 2017)

IMMUCELLCORPORATION Amendmentto Construction Loan Agreement between the Company and TD Bank N.A. dated March1, 2017. AMENDMENTTO CONSTRUCTION LOAN AGREEMENT (Filed With SEC on March 30, 2017)

IMMUCELLCORPORATION MortgageLoan Note for $340,000 given by the Company in favor of TD Bank N.A. dated March 16, 2017. (Filed With SEC on March 30, 2017)

Estimate Totals (Filed With SEC on November 10, 2016)

Registration Rights Agreement dated October 17, 2016 (Filed With SEC on October 21, 2016)

Securities Purchase Agreement dated October 17, 2016 (Filed With SEC on October 21, 2016)

1,123,810Shares ImmuCellCorporation CommonStock, par value $0.10 per share PURCHASEAGREEMENT (Filed With SEC on January 29, 2016)

ImmuCell Corporation EXHIBIT10.1 SupplyAgreement between the Company and Plas-Pak Industries, Inc. datedas of October 14, 2015. (Filed With SEC on November 12, 2015)

ImmuCell Corporation EXHIBIT4.1 AMENDMENTTO RIGHTS AGREEMENT (Filed With SEC on May 12, 2015)

EXHIBIT 4.1D AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on June 17, 2014)

ImmuCell Corporation EXHIBIT 4.1 THIRD AMENDMENT TO RIGHTS AGREEMENT DATED AS OF AUGUST 9, 2011 (Filed With SEC on August 15, 2011)

ImmuCell Corporation Exhibit 10.6 2010 Stock Option and Incentive Plan of the Company EXHIBIT A 2010 STOCK OPTION AND INCENTIVE PLAN I. GENERAL (Filed With SEC on March 28, 2011)

ImmuCell Corporation Exhibit 10.7 Form of Incentive Stock Option Agreement IMMUCELL CORPORATION 2010 STOCK OPTION AND INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 28, 2011)

CONTRACT MANUFACTURE AGREEMENT (Filed With SEC on November 8, 2010)

ImmuCell Corporation (Filed With SEC on August 16, 2010)

ImmuCell Corporation Commercial Promissory Note for $600,000 between the Company and TD Bank, N.A. datedAugust 13, 2010. ImmuCell Corporation COMMERCIAL PROMISSORY NOTE (Filed With SEC on August 16, 2010)

ImmuCell Corporation (Filed With SEC on August 16, 2010)

ImmuCell Corporation Loan Agreement between the Company and TD Bank, N.A. dated August 13, 2010. (Filed With SEC on August 16, 2010)

IMMUCELL CORPORATION EXHIBIT 10.6 AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 29, 2010)

IMMUCELL CORPORATION EXHIBIT 10.7 AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 29, 2010)

IMMUCELL CORPORATION and AMERICAN STOCK TRANSFER & TRUST CO. Rights Agent (Filed With SEC on May 5, 2009)

IMMUCELL CORPORATION EXHIBIT 10.2 FORM OF INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 27, 2009)

IMMUCELL CORPORATION EXHIBIT 4.1A SECOND AMENDMENT TO RIGHTS AGREEMENT DATED AS OF JUNE 30, 2008 (Filed With SEC on March 27, 2009)

IMMUCELL CORPORATION EXHIBIT 10.1 1989 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 27, 2009)

IMMUCELL CORPORATION EXHIBIT 10.7 FORM OF INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 27, 2009)

IMMUCELL CORPORATION EXHIBIT 10.4 EMPLOYMENT AGREEMENT DATED APRIL 29, 1999 BETWEEN THE REGISTRANT (Filed With SEC on March 27, 2009)

IMMUCELL CORPORATION EXHIBIT 10.5 EMPLOYMENT AGREEMENT DATED APRIL 29, 1999 BETWEEN THE REGISTRANT (Filed With SEC on March 27, 2009)

IMMUCELL CORPORATION EXHIBIT 10.6 2000 STOCK OPTION AND INCENTIVE PLAN OF THE REGISTRANT (Filed With SEC on March 27, 2009)

SECOND AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on July 1, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on July 28, 2005)

AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on July 5, 2005)

LICENSE AGREEMENT (Filed With SEC on March 29, 2005)

EMPLOYMENT AGREEMENT (Filed With SEC on January 4, 2005)

LICENSE AND SUBLICENSE AGREEMENT (Filed With SEC on November 19, 2004)

Category

Industry

Companies

Contracts

IMMUCELL CORP Contracts & Agreements